Modeling of Lowe Patient-Derived Induced Pluripotent Stem Cells Into Trabecular Meshwork.

Yang Sun1, Tia J Kowal2, Yingchun Shen2

  • 1From the Department of Ophthalmology (Y.S., T.J.K., Y.S., J.Z., B.W., C.H.L.), Stanford University School of Medicine, Palo Alto, California, USA; Palo Alto Veterans Administration (Y.S.), Palo Alto, California, USA.

Summary

Researchers developed patient-derived trabecular meshwork cells to study Lowe syndrome (LS) glaucoma. OCRL deficiency in these cells revealed defects in phagocytosis, cilia, and lysosome function, offering new models for LS research.

Related Concept Videos